Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer

Erlisa Bardhi,Claudia Marchetti,Annalisa Scopelliti,Lucia Musacchio,Federica Tomao,Michele Carlo Schiavi,Carlo Carraro,Innocenza Palaia,Marco Monti,Ludovico Muzii,Pierluigi Benedetti-Panici

Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer

2019

Erlisa Bardhi
Claudia Marchetti
Annalisa Scopelliti
Lucia Musacchio
Federica Tomao
Michele Carlo Schiavi
Carlo Carraro
Innocenza Palaia
Marco Monti
Ludovico Muzii
Pierluigi Benedetti-Panici

ABSTRACTIntroduction: A PEGylated form of irinotecan, a topoisomerase I inhibitor, is now available in commerce; its safety and efficacy have been tested in platinum resistant/refractory ovarian ca...

Keywords:

Pharmacology
Ovarian cancer
Etirinotecan pegol
Refractory
Internal medicine
Diabetes mellitus
Oncology
Medicine
platinum resistant
Topoisomerase-I Inhibitor
Irinotecan

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations